CLINICAL TRIAL
JOURNAL ARTICLE
MULTICENTER STUDY
Add like
Add dislike
Add to saved papers

Iris-claw lens in phakic eyes to correct hyperopia: preliminary study.

PURPOSE: To evaluate the results of implanting convex, iris-fixated, anterior chamber intraocular lenses (IOLs) in phakic eyes to correct high hyperopia.

SETTING: Robert Koch Hospital, Hannover-Gehrden, Germany (Center A), and Dr. Daljit Singh Eye Hospital, Amritsar, India (Center B).

METHOD: Two eyes at Center A and 67 at Center B had implantation of an anterior chamber, convex, iris-fixated IOL. Follow-up of the 2 eyes at Center A was 91 months. Mean follow-up at Center B was 78 months +/- 24 (SD) (range 12 to 120 months).

RESULTS: At Center B, all eyes except two in one patient had clear corneas and no iritis or glaucoma at the last follow-up. The patient with complications (glaucoma and corneal degeneration in both eyes) did not return for follow-up until more than 4 years postoperatively and thus did not have adequate postoperative care.

CONCLUSION: Implantation of a convex iris-claw lens into the anterior chamber of phakic eyes to correct high hyperopia was successful from a refractive aspect. The clinical risks appear tolerable. However, life-long observation by endothelial microscopy is mandatory.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app